Home
University & Research Institutions

Sector: University & Research Institutions

A roadmap for industry-academia collaboration to advance IP policy

Ethical and transparent partnerships can help resolve pressing issues all while furthering a company’s goals and interests

Boston Scientific ordered to hand University of Texas $42 million in David-versus-Goliath dispute

But patentee worried further action could ‘exhaust’ it as MedTech company moves to appeal

New US trade secrets law a ‘potential sledgehammer’ in dispute negotiations

President can now pick out foreign entities and subject them to a series of sanctions

Latest content

English High Court backs Oxford University in landmark tech transfer IP ruling

OUI’s patent policies were not unfair to spinout co-founder under consumer protection laws

31 January 2023

The FTC’s war against US technology competition with China

Saturday Opinion: Supporting the legality of fair non-compete agreements will enhance foreign investors’ reasonable expectations of protection by the US IP system

28 January 2023

We are willing to litigate our CRISPR patents, says IP chief on the CVC side

ERS Genomics’ Michael Arciero shares his views on the Cas9 licensing landscape in an exclusive IAM interview

24 January 2023

Prepare now: call to action for chief IP officers on draft FTC non-compete policy

Commission may face legal challenges but risks of trade secrets breaches and increased litigation abound

13 January 2023

US omnibus appropriations bill: robust USPTO funding and satellite office incoming

Unleashing American Innovators in, Pride in Patent Ownership out of bill which is expected to hit Biden’s desk on Friday

20 December 2022

An almost billion-dollar award leads 2022’s top 10 US patent verdicts

Companies who scored the most from US juries during the past 12 months include VLSI Technology, Complete Genomics Inc, Ravgen Inc, USAA and Columbia University

19 December 2022

Patent bills prominent but prospects mixed as US Congress winds down

Controversial Pride in Patent Ownership bill unlikely, other bills passed or possible

16 December 2022

Diversity data reveals size of missed opportunities in inventors and patenting

Qualcomm executive and Invent Together director discuss initiatives at IP Dealmakers conference in New York

13 December 2022

Your guide to synthetic drug royalty dealmaking

Selling revenue streams is an increasingly important way of monetising pharma innovations

16 November 2022

Drug royalty agreements can help Big Pharma overcome patent cliffs, says top dealmaker

Behzad Khosrowshahi, CEO of DRI Healthcare Trust, looks at recent deals the firm has done, explains what makes a transaction attractive and how to get one over the line

04 November 2022

Unlock unlimited access to all IAM content